Capricor Therapeutics
CAPR
#5197
Rank
NZ$2.66 B
Marketcap
NZ$48.95
Share price
14.18%
Change (1 day)
84.93%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: NZ$2.66 Billion

As of February 2026 Capricor Therapeutics has a market cap of NZ$2.66 Billion. This makes Capricor Therapeutics the world's 5197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.66 B-1.77%
2025NZ$2.71 B143.04%
2024NZ$1.11 B368.44%
2023NZ$0.23 B55.16%
2022NZ$0.15 B47.92%
2021NZ$0.10 B6.06%
2020NZ$97.81 M884.57%
2019NZ$9.93 M-48.22%
2018NZ$19.18 M-66.46%
2017NZ$57.19 M-30.39%
2016NZ$82.17 M12.57%
2015NZ$72.99 M30.28%
2014NZ$56.03 M21.22%
2013NZ$46.22 M1713.24%
2012NZ$2.54 M-90.81%
2011NZ$27.72 M-0.37%
2010NZ$27.82 M-38.32%
2009NZ$45.12 M27.57%
2008NZ$35.37 M-79.56%
2007NZ$0.17 B3936.66%
2006NZ$4.28 M-40.3%
2005NZ$7.17 M4.4%
2004NZ$6.87 M16.11%
2003NZ$5.92 M-70.67%
2002NZ$20.19 M

End of Day market cap according to different sources

On Feb 19th, 2026 the market cap of Capricor Therapeutics was reported to be:

NZ$2.53 Billion
by Nasdaq info icon info icon
NZ$2.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$999.17 B 37,423.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$21.92 B 723.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$13.92 B 422.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$2.62 B-1.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$60.04 M-97.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$18 M-99.32%๐Ÿ‡บ๐Ÿ‡ธ USA